# A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants

> **NCT07673120** · PHASE1 · RECRUITING · sponsor: **AbbVie** · enrollment: 64 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ABBV-313
- **DRUG:** Placebo
- **DRUG:** ABBV-313
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07673120
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673120, "A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*